Updated:
TCP Health Ventures
Early Stage MedTech Venture Capital | TCP Health Ventures is the dedicated healthcare investment arm of The Capital Partnership group of companies, a...
TCP Health Ventures
Early Stage MedTech Venture Capital | TCP Health Ventures is the dedicated healthcare investment arm of The Capital Partnership group of companies, a multi-asset investment company with assets under management of US$7 billion.
General information
Firm type
Venture Capital
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Sector focus
Frequently asked questions
What investment stages does TCP Health Ventures target?
TCP Health Ventures focuses on early-stage investments, primarily Seed and Series A rounds. The firm occasionally participates in follow-on financings for existing portfolio companies. This stage focus allows it to partner with founders during the critical clinical validation and early commercialization phases.
Which sectors or sub-sectors does the firm concentrate on?
The firm invests exclusively in digital health, covering software, tech-enabled services, and data platforms. Sub-sectors of interest include clinical workflow tools, digital therapeutics, patient engagement platforms, and administrative automation for providers and payers. This is a single-sector mandate with no diversification into other technology verticals.
What is TCP Health Ventures' known posture on follow-on funding?
TCP Health Ventures maintains capacity for follow-on investments in its portfolio companies, though the specific reserve strategy has not been publicly detailed. Like most early-stage specialists, the firm expects to support its strongest performers through subsequent financing rounds, often alongside new later-stage investors.
How does a single-sector health mandate shape the firm's risk profile?
The firm's exclusive focus on digital health concentrates both its expertise and its portfolio risk within one vertical. This narrow aperture allows deep specialization in healthcare reimbursement, regulation, and clinical adoption cycles, but it also means the portfolio is highly correlated to sector-specific headwinds such as policy changes or health system budget cycles.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Source record modified: . Public records carry source-specific dates where available. No population-wide measured refresh cadence or universal verification deadline is established here. Page modified, source captured, fact observed, entity verified and aggregate measured describe different events. Check the date attached to the relevant claim; a missing verification date means unknown. Stored source history does not establish a customer-facing historical-analysis interface. To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: